John M. Wrangle, M.D. and Mark P. Rubinstein, Ph.D., launch the first clinical trial combing two therapies for advanced lung cancer – hoping for the drug to kick-start patients' ability to fight back against the disease.
See recent peer-reviewed publications from HCC physicians, researchers and postdoctoral trainees.
Visit the News Center to see the latest news and feature events from the University, MUSC Health and local health care.